Review of Ruxolitinib in the Treatment of Atopic Dermatitis.
Lindsey A MohneyRohan SinghSteven Richard FeldmanPublished in: The Annals of pharmacotherapy (2022)
Data from phase II and III clinical trials in adult patients suggest RUX is an effective and safe therapy for AD.